Literature DB >> 8747229

Acute activation and inactivation of macaque frontal eye field with GABA-related drugs.

E C Dias1, M Kiesau, M A Segraves.   

Abstract

1. This project tests the behavioral effects of reversible activation and inactivation of sites within the frontal eye field of rhesus monkeys with microinjections of the gamma-aminobutyric acid (GABA)-related drugs bicuculline and muscimol. 2. Muscimol injections impaired the monkeys' ability to make both visually and memory-guided saccades to targets at the center of the area represented by the injection site. The latencies of saccades to targets in regions flanking the injection were increased. For memory-guided saccades, saccades in the direction opposite to that represented by the injection site, were made with shorter latency than controls and often occurred before the movement cue. 3. Bicuculline injections produced irrepressible saccades equivalent to the saccade vector represented by the injection site, often in a staircase of several closely spaced movements. 4. Both substances decreased the accuracy of fixation of a central light. The distribution of points of fixation on different trials was diffuse, and the angle of gaze tended to deviate towards the side of the injection. 5. The results of these acute injections are similiar to those observed in the superior colliculus and are much more substantial than the effects observed in the long term after surgical removal of the frontal eye field. The results of this study promote a central role for the frontal eye field in the generation of all voluntary saccades and in the control of fixation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747229     DOI: 10.1152/jn.1995.74.6.2744

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  25 in total

1.  Neuronal correlates for preparatory set associated with pro-saccades and anti-saccades in the primate frontal eye field.

Authors:  S Everling; D P Munoz
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 2.  The neural selection and control of saccades by the frontal eye field.

Authors:  Jeffrey D Schall
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-08-29       Impact factor: 6.237

3.  Deficits in reach target selection during inactivation of the midbrain superior colliculus.

Authors:  Joo-Hyun Song; Robert D Rafal; Robert M McPeek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

4.  Rapid enhancement of visual cortical response discriminability by microstimulation of the frontal eye field.

Authors:  Katherine M Armstrong; Tirin Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

5.  A microcircuit model of the frontal eye fields.

Authors:  Jakob Heinzle; Klaus Hepp; Kevan A C Martin
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

6.  Modulation of presaccadic activity in the frontal eye field by the superior colliculus.

Authors:  Rebecca A Berman; Wilsaan M Joiner; James Cavanaugh; Robert H Wurtz
Journal:  J Neurophysiol       Date:  2009-03-25       Impact factor: 2.714

7.  Saliency and saccade encoding in the frontal eye field during natural scene search.

Authors:  Hugo L Fernandes; Ian H Stevenson; Adam N Phillips; Mark A Segraves; Konrad P Kording
Journal:  Cereb Cortex       Date:  2013-07-17       Impact factor: 5.357

8.  FEF inactivation with improved optogenetic methods.

Authors:  Leah Acker; Erica N Pino; Edward S Boyden; Robert Desimone
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-02       Impact factor: 11.205

9.  Pulvinar inactivation disrupts selection of movement plans.

Authors:  Melanie Wilke; Janita Turchi; Katy Smith; Mortimer Mishkin; David A Leopold
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

Review 10.  A computational model for cerebral cortical dysfunction in autism spectrum disorders.

Authors:  Shashaank Vattikuti; Carson C Chow
Journal:  Biol Psychiatry       Date:  2009-10-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.